Materials and methods: Patients aged >60
years with stage III colon cancer referred for adjuvant chemotherapy between 2010–2012 were
identified from a tertiary hospital oncology database. Data were collected on
demographics, chemotherapy received, completion rates, toxicities, relapse and
survival.
Comparison was made between the older group
(age >70 years) and the younger group (age 60-70 years). 95 eligible
patients were identified; 50 in the older group (median age 76), 45 in the
younger group (median age 66), 56% male, 82% NZ European and 5% Maori.
No comments:
Post a Comment